Personalized use of ketamine and esketamine for treatment-resistant depression
Gustavo C Medeiros, Isabella Demo, Fernando S Goes, Carlos A Zarate, Todd D Gould · 2024
Read Personalized use of ketamine and esketamine for treatment-resistant depression by Gustavo C Medeiros, Isabella Demo, Fernando S Goes, Carlos A Zarate, Todd D Gould (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11607365.txt.
Description
Gustavo Medeiros and colleagues map personal use of ketamine drugs for stubborn depression, in a review from 2024. Treatment resistant depression drives much of the total burden of major depression care. Vein ketamine and nasal esketamine act fast, yet patient response varies widely in practice.
Family history of alcohol problems hints at stronger response before treatment starts. Childhood trauma history also joins the hint list for robust response in trials. Brain wave shifts in front and side zones form a rising sign of response. Blood marks proved weak, with one growth factor showing small steady rises. Combined models will be needed since each hint alone is modest.
Catalog record
| CREATOR | Gustavo C Medeiros, Isabella Demo, Fernando S Goes, Carlos A Zarate, Todd D Gould |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |